Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Pfizer CEO on the company's future: 'We are investing in science'
Yahoo Finance on Twitter: "$TEVA Pharmaceutical is set to pay $4.25 billion in settlements in opioid cases, $CS names new CEO, $DB warns of challenging second half for 2022, and $TWTR is